![]() |
Name |
(2E,4E)-2,4-Dodecadienal
|
Molecular Formula | C12H20O | |
IUPAC Name* |
(2E,4E)-dodeca-2,4-dienal
|
|
SMILES |
CCCCCCC/C=C/C=C/C=O
|
|
InChI |
InChI=1S/C12H20O/c1-2-3-4-5-6-7-8-9-10-11-12-13/h8-12H,2-7H2,1H3/b9-8+,11-10+
|
|
InChIKey |
QKTZBZWNADPFOL-BNFZFUHLSA-N
|
|
Synonyms |
21662-16-8; (E,E)-2,4-dodecadienal; (2E,4E)-Dodeca-2,4-dienal; 2,4-Dodecadienal; (2E,4E)-2,4-Dodecadienal; Trans,trans-2,4-dodecadienal; 2,4-Dodecadienal, (E,E)-; (E,E)-2,4-Dodecadien-1-al; 2,4-Dodecadien-1-al; (trans,trans)-2,4-Dodecadienal; 2,4-Dodecadienal, (2E,4E)-; FEMA No. 3670; 2,4-Dodecadienal, trans,trans-; VO340RJ9LU; 2e,4e-dodecadienal; UNII-VO340RJ9LU; 13162-47-5; (2e,4z)-2,4-dodecadienal; SCHEMBL229448; SCHEMBL229806; FEMA 3670; DTXSID80885175; CHEBI:171898; 21662-15-7; ZINC2016114; EINECS 244-517-1; MFCD00014678; 2-TRANS-4-TRANS-DODECADIENAL; AKOS015902294; AS-76766; 2,4-DODECADIEN-1-AL, (E,E)-; 2,4-Dodecadienal, technical, >=90% (GC); EN300-303371; 662T168; J-014218; Q27291932; TRANS,TRANS-2,4-DODECADIENAL, (2E,4E)- [FHFI]
|
|
CAS | 21662-16-8 | |
PubChem CID | 5367530 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 180.29 | ALogp: | 4.3 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 13 | QED Weighted: | 0.235 |
Caco-2 Permeability: | -4.601 | MDCK Permeability: | 0.00002150 |
Pgp-inhibitor: | 0.097 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.014 |
30% Bioavailability (F30%): | 0.075 |
Blood-Brain-Barrier Penetration (BBB): | 0.996 | Plasma Protein Binding (PPB): | 66.37% |
Volume Distribution (VD): | 1.688 | Fu: | 16.74% |
CYP1A2-inhibitor: | 0.648 | CYP1A2-substrate: | 0.709 |
CYP2C19-inhibitor: | 0.23 | CYP2C19-substrate: | 0.709 |
CYP2C9-inhibitor: | 0.099 | CYP2C9-substrate: | 0.835 |
CYP2D6-inhibitor: | 0.068 | CYP2D6-substrate: | 0.825 |
CYP3A4-inhibitor: | 0.15 | CYP3A4-substrate: | 0.195 |
Clearance (CL): | 4.247 | Half-life (T1/2): | 0.584 |
hERG Blockers: | 0.053 | Human Hepatotoxicity (H-HT): | 0.451 |
Drug-inuced Liver Injury (DILI): | 0.018 | AMES Toxicity: | 0.845 |
Rat Oral Acute Toxicity: | 0.873 | Maximum Recommended Daily Dose: | 0.792 |
Skin Sensitization: | 0.986 | Carcinogencity: | 0.66 |
Eye Corrosion: | 0.986 | Eye Irritation: | 0.987 |
Respiratory Toxicity: | 0.963 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001808 | ![]() |
0.838 | D0O1TC | ![]() |
0.370 | ||
ENC001600 | ![]() |
0.838 | D0UE9X | ![]() |
0.362 | ||
ENC001599 | ![]() |
0.789 | D0O1PH | ![]() |
0.304 | ||
ENC001601 | ![]() |
0.732 | D0OR6A | ![]() |
0.283 | ||
ENC001598 | ![]() |
0.711 | D0Z5BC | ![]() |
0.281 | ||
ENC001597 | ![]() |
0.632 | D05ATI | ![]() |
0.273 | ||
ENC000032 | ![]() |
0.550 | D06FEA | ![]() |
0.262 | ||
ENC001587 | ![]() |
0.522 | D09SRR | ![]() |
0.258 | ||
ENC001552 | ![]() |
0.516 | D01QLH | ![]() |
0.255 | ||
ENC001654 | ![]() |
0.513 | D0AY9Q | ![]() |
0.254 |